BKV Corp·4

Mar 12, 2:08 PM ET

Tameron David 4

4 · BKV Corp · Filed Mar 12, 2026

Research Summary

AI-generated summary of this filing

Updated

BKV Corp (BKV) CFO David Tameron Receives 30,407 RSU Award

What Happened

  • David Tameron, Chief Financial Officer of BKV Corporation, was granted 30,407 restricted stock units (RSUs) on March 10, 2026. The grant is reported as an award (transaction code A) with a reported acquisition price of $0.00, meaning no cash was paid by the insider at grant. Each RSU represents a contingent right to receive one share of common stock upon vesting.

Key Details

  • Transaction date: March 10, 2026; Form 4 filed March 12, 2026 (timely filing).
  • Grant size and price: 30,407 RSUs granted at $0.00 (award).
  • Vesting: RSUs vest in three equal annual installments beginning March 10, 2027 (see footnote).
  • Shares owned after transaction: not disclosed in the provided filing details.
  • Footnote summary: Each RSU converts to one share when vested under the BKV Corporation 2024 Equity and Incentive Compensation Plan.
  • Transaction code: A = Award/Grant. No indication of tax withholding, 10b5-1 plan, or sale of underlying shares in this filing.

Context

  • This is a time‑based equity award, not an open‑market purchase or sale. Such grants are commonly used for executive compensation and are contingent on continued service and the stated vesting schedule; they do not reflect an immediate cash investment or disposition by the insider.

Insider Transaction Report

Form 4
Period: 2026-03-10
Tameron David
Chief Financial Officer
Transactions
  • Award

    Common Stock

    [F1]
    2026-03-10+30,40769,225 total
Holdings
  • Common Stock

    (indirect: By Son)
    300
  • Common Stock

    (indirect: By Son)
    300
Footnotes (1)
  • [F1]Represents restricted stock units granted to the reporting person under the BKV Corporation 2024 Equity and Incentive Compensation Plan that vest in three equal annual installments beginning on March 10, 2027. Each restricted stock unit represents a contingent right to receive one share of common stock, par value $0.01 per share.
Signature
/s/ Kathleen Lenox, attorney-in-fact|2026-03-12

Documents

1 file
  • 4
    wk-form4_1773338900.xmlPrimary

    FORM 4